Pharmacological Action Clinical Trial
Official title:
Baricitinib Combined With Antiviral Therapy in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study
There is no specific antiviral treatment recommended for COVID-19, and no vaccine is currently available. Baricitinib, an anti-Janus kinase inhibitor (anti-JAK) acting against JAK1 and JAK2. The drug was found capable to reduce or interrupt the passage of the virus into target cells, and to inhibit the JAK1- and JAK2-mediated cytokine release. The drug was licensed for the treatment of rheumatoid arthritis at the daily dose of 4 mg/orally, with excellent results in terms of clinical response and a good safety profile. Since baricitinib does not interact with antivirals due to its prevalent renal elimination, it may be used in combination.The evidence on the advantageous action of baricitinib on viral entry and cytokine outbreak constituted the rationale to perform a trial on patients with mild to moderate COVID-19 infection receiving baricitinib combined with antiviral therapy.
Study design. Interventional, open-label, 2-week, prospective trial of a cohort of patients
with mild to moderate COVID-19 infection.
Objectives. Primary. To assess the efficacy of baricitinib combined with antiviral therapy in
patients with COVID-19-related mild and moderate disease in terms of reduction of the
percentage of subjects requiring ICU admission.
Secondary objectives. To describe the clinical findings in a cohort of symptomatic
COVID-19-infected subjects; to investigate the role of CRP, IL-6, and TNFα levels as
predictor of progression to ARDS; to assess the type and incidence of adverse events (AEs).
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06040853 -
Postoperative Pain in Laparoscopic Radical Prostatectomy Surgery With Tranexamic Acid: Analgesia? Hiperalgesia?
|
Phase 4 | |
| Not yet recruiting |
NCT05553496 -
Assessment of Rituximab Therapeutic Response Versus Conventional Treatment
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05534802 -
Ulinastatin Improves and Prevents Cardiac Dysfunction Induced by Cardiopulmonary Bypass
|
N/A | |
| Recruiting |
NCT04190537 -
PARADOX - the Incidence of Paradoxical Reactions in Pediatric Patients Premedicated With Midazolam
|
||
| Completed |
NCT03522532 -
Dental Restorations Effect on Oxidative Status of the Gingival Crevicular Fluid
|
N/A | |
| Completed |
NCT03119454 -
"Corticoid-16" in Long Term When Administered Systemically in Patients in Routine Medical Practice
|
N/A | |
| Unknown status |
NCT01614353 -
Medication-taking Preferences & Practices of Patients With Chronic Conditions
|
N/A | |
| Completed |
NCT03714360 -
The Effect of Tranexamic Acid. A Randomised Study of Patients Undergoing Elective Lumbar Spine Surgery.
|
Phase 4 | |
| Recruiting |
NCT03352622 -
Pharmacogenomic in Colombian Patients With Rheumatoid Arthritis
|
N/A | |
| Recruiting |
NCT06288841 -
Efficacy and Safety of Liposomal Bupivacaine Under ERAS Concept for Postoperative Analgesia of Ultrasound-Guided QLB in Gynecologic Laparoscopic Patients: A Randomized, Single-blind, Active-Controlled Clinical Study
|
N/A | |
| Completed |
NCT03359590 -
Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes Patients
|
Phase 2 | |
| Completed |
NCT05591105 -
Morphine Consumption in the Obese Patients
|
||
| Not yet recruiting |
NCT03904303 -
Test of a New Gel-based Colon Cleansing Agent Compared to Moviprep
|
Phase 1 | |
| Not yet recruiting |
NCT05453045 -
Pharmacokinetics and Excretion of Albendazole and Its Metabolites in Saliva
|
N/A | |
| Completed |
NCT05428683 -
Intravitreal Triamcinolone and Moxifloxacin Injection After Cataract Surgery
|
N/A | |
| Enrolling by invitation |
NCT02985281 -
Safety and Efficacy of Gratisovir (Sofosbuvir)- Ribavirin Therapy in Pediatric Patients
|
Phase 2/Phase 3 | |
| Recruiting |
NCT06222710 -
Ultrasound Guiding Pharmacopuncture Therapy for Supraspinatus Tendinopathy
|
N/A | |
| Not yet recruiting |
NCT03953287 -
Pharmacokinetic Study of Paracetamol.
|
Phase 1 | |
| Recruiting |
NCT03622047 -
Comparison of Epidural Labor Analgesia With Dexmedetomidine or Sufentanil
|
N/A | |
| Active, not recruiting |
NCT06324370 -
Exploratory Pharmacokinetic Study of Virgin Coconut Oil (VCO)
|
N/A |